Loading…
Loading…
Remote · PA · United States
Research provider: Pitt+Me
Have you ever had pancreatitis? Do you also have diabetes? If you have recurrent acute pancreatitis, chronic pancreatitis or developed diabetes after an episode of acute pancreatitis, you may be eligible for a drug trial testing two FDA approved diabetes medication. Study participation involves up to 4 clinic visits and up to 6 phone or video visits over a 26-week period.
Study participation involves up to 4 scheduled clinic visits and up to 6 scheduled phone or video visits over a 26-week period. There are two phases to the study described below. At the screening visit, the study team will provide you with a continuous glucose monitor (CGM) that you will wear for 10 days. We will call this the run-in phase. After the run-in phase, you will return to be randomized to one of two FDA-approved medication groups, Empagliflozin (EMPA) or Pioglitazone (PIO). These medications will be provided by the study. This phase will last about 6 months. Each group will follow the same visit format described later in this form.
Have you ever had pancreatitis? Do you also have diabetes? If you have recurrent acute pancreatitis, chronic pancreatitis or developed diabetes after an episode of acute pancreatitis, you may be eligible for a drug trial testing two FDA approved diabetes medication. Study participation involves up to 4 clinic visits and up to 6 phone or video visits over a 26-week period.
Review the provider’s screening questions. These requirements do not guarantee selection.